Bengaluru, Sept 29 : The country’s drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax’s COVID-19 vaccine. “After
Bengaluru, Sept 29 : The country’s drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax’s COVID-19 vaccine. “After